Mass spectrometry approaches to monitor protein–drug interactions
Recent advances in mass spectrometry-based approaches have enabled the investigation
of drug–protein interactions in various ways including the direct detection of drug–target …
of drug–protein interactions in various ways including the direct detection of drug–target …
Preparation of (−)-Nutlin-3 using enantioselective organocatalysis at decagram scale
TA Davis, AE Vilgelm, A Richmond… - The Journal of organic …, 2013 - ACS Publications
Chiral nonracemic cis-4, 5-bis (aryl) imidazolines have emerged as a powerful platform for
the development of cancer chemotherapeutics, stimulated by the Hoffmann-La Roche …
the development of cancer chemotherapeutics, stimulated by the Hoffmann-La Roche …
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
2009-03-30 Assigned to THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
reassignment THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION ASSIGNMENT …
reassignment THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION ASSIGNMENT …
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors
2010-09-20 Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), US DEPT. OF HEALTH
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …
AND HUMAN SERVICES (DHHS), US GOVERNMENT reassignment NATIONAL …
MicroRNA expression profiling and targeting in peripheral blood in lung cancer
SP Nana-Sinkam, CB Marsh, MG Piper… - US Patent App. 12 …, 2010 - Google Patents
US20100323357A1 - MicroRNA Expression Profiling and Targeting in Peripheral Blood in
Lung Cancer - Google Patents US20100323357A1 - MicroRNA Expression Profiling and …
Lung Cancer - Google Patents US20100323357A1 - MicroRNA Expression Profiling and …
Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
The invention provides methods and compositions for the treatment of cancers associated
with overexpression of a BCL2 gene and/or gene productina Subject, and methods and …
with overexpression of a BCL2 gene and/or gene productina Subject, and methods and …
MicroRNA Signatures in Human Ovarian Cancer
CM Croce - US Patent App. 12/676,670, 2010 - Google Patents
S&S 8888 Sssssssssss-six sass Sex: sis) is is says hSa-mir-200C 5.6 O2789 113584732
4.285621 5.1693. 7934 hSa-mir-141 6.66868 8.134845605 3.175124 4.632327322 hSa-mir …
4.285621 5.1693. 7934 hSa-mir-141 6.66868 8.134845605 3.175124 4.632327322 hSa-mir …
Methods and compositions for inducing deregulation of EPHA7 and ERK phosphorylation in human acute leukemias
CM Croce - US Patent 8,466,119, 2013 - Google Patents
5,567,586 A 10, 1996 Croce 5,595,869 A 1/1997 Tsujimoto et al. 5,633,135 A 5, 1997
Croceet al.(57) ABSTRACT 5,633,136 A 5, 1997 Croceet al. Methods for assessing a …
Croceet al.(57) ABSTRACT 5,633,136 A 5, 1997 Croceet al. Methods for assessing a …
Methods and compositions for the diagnosis and treatment of esphageal adenocarcinomas
This invention relates generally to the field of molecular biology. More particularly, it
concerns methods and compositions involving biomarkers for esophageal cancer and …
concerns methods and compositions involving biomarkers for esophageal cancer and …
MiR-29-based methods for the diagnosis and prognosis of acute myeloid leukemia (AML)
CM Croce - US Patent 8,530,159, 2013 - Google Patents
US8530159B2 - MiR-29-based methods for the diagnosis and prognosis of acute myeloid
leukemia (AML) - Google Patents US8530159B2 - MiR-29-based methods for the diagnosis …
leukemia (AML) - Google Patents US8530159B2 - MiR-29-based methods for the diagnosis …